OBIO
Price
$3.17
Change
+$0.02 (+0.63%)
Updated
Jul 17 closing price
Capitalization
121.45M
XBIT
Price
$3.00
Change
+$0.02 (+0.67%)
Updated
Jul 17 closing price
Capitalization
91.46M
28 days until earnings call
Interact to see
Advertisement

OBIO vs XBIT

Header iconOBIO vs XBIT Comparison
Open Charts OBIO vs XBITBanner chart's image
Orchestra BioMed Holdings
Price$3.17
Change+$0.02 (+0.63%)
Volume$152.72K
Capitalization121.45M
XBiotech
Price$3.00
Change+$0.02 (+0.67%)
Volume$54.33K
Capitalization91.46M
OBIO vs XBIT Comparison Chart in %
Loading...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OBIO vs. XBIT commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBIO is a Hold and XBIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (OBIO: $3.17 vs. XBIT: $3.00)
Brand notoriety: OBIO and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OBIO: 56% vs. XBIT: 51%
Market capitalization -- OBIO: $121.45M vs. XBIT: $91.46M
OBIO [@Biotechnology] is valued at $121.45M. XBIT’s [@Biotechnology] market capitalization is $91.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OBIO’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • OBIO’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OBIO’s TA Score shows that 5 TA indicator(s) are bullish while XBIT’s TA Score has 4 bullish TA indicator(s).

  • OBIO’s TA Score: 5 bullish, 4 bearish.
  • XBIT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than XBIT.

Price Growth

OBIO (@Biotechnology) experienced а +5.67% price change this week, while XBIT (@Biotechnology) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

OBIO is expected to report earnings on May 12, 2025.

XBIT is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($121M) has a higher market cap than XBIT($91.5M). OBIO YTD gains are higher at: -20.750 vs. XBIT (-24.051). XBIT has higher annual earnings (EBITDA): -36.99M vs. OBIO (-68.48M). XBIT has more cash in the bank: 156M vs. OBIO (49.9M). XBIT has less debt than OBIO: XBIT (10M) vs OBIO (16.4M). OBIO has higher revenues than XBIT: OBIO (2.89M) vs XBIT (0).
OBIOXBITOBIO / XBIT
Capitalization121M91.5M132%
EBITDA-68.48M-36.99M185%
Gain YTD-20.750-24.05186%
P/E RatioN/AN/A-
Revenue2.89M0-
Total Cash49.9M156M32%
Total Debt16.4M10M164%
FUNDAMENTALS RATINGS
XBIT: Fundamental Ratings
XBIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OBIOXBIT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
67%
Declines
ODDS (%)
Bearish Trend 18 days ago
72%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GULRY15.52N/A
N/A
Guoco Group Ltd.
YNAJF0.82N/A
N/A
Yantai North Andre Juice Co., Ltd.
PTPIF0.53N/A
N/A
PT Chandra Asri Pacific Tbk
LCNTU511.00N/A
N/A
Louisiana Central Oil & Gas Co.
STBXF0.25-0.15
-36.84%
Starbox Group Holdings Ltd

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+0.63%
GBIO - OBIO
41%
Loosely correlated
-7.72%
XBIT - OBIO
40%
Loosely correlated
+0.67%
GLSI - OBIO
40%
Loosely correlated
+9.92%
RXRX - OBIO
39%
Loosely correlated
+5.75%
ABEO - OBIO
39%
Loosely correlated
+5.91%
More